AIC
GALT icon

Ameritas Investment Company’s Galectin Therapeutics GALT Stock Holding History

Ameritas Investment Company’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$172K Buy
44,232
+5,000
+13% +$16.9K 0.01% 687
2021
Q2 		$126K Buy
+39,232
New +$140K 0.01% 715
2021
Q1 		– Sell
-10,782
Closed -$24K – 2253
2020
Q4 		$24K Hold
10,782
– – ﹤0.01% 422
2020
Q3 		$33K Hold
10,782
– – 0.01% 331
2020
Q2 		$33K Sell
10,782
-2,500
-19% -$6.29K 0.01% 338
2020
Q1 		$25K Buy
13,282
+2,500
+23% +$6.08K ﹤0.01% 928
2019
Q4 		$31K Buy
+10,782
New +$37.5K 0.01% 630

Other funds holding GALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Ameritas Investment Company's GALT Position: Q3 2021 in Review

Ameritas Investment Company increased its Galectin Therapeutics (GALT) stake by 13% in Q3 2021, buying an estimated $16.9K and bringing the position to 44,232 shares worth $172K. The position accounts for 0.01% of the portfolio, ranked #687.

Ameritas Investment Company first reported a position in GALT in Q4 2019 and has held it in 7 quarters since. 70 funds tracked by Wall St. Rank hold GALT as of Q3 2021.

  • Ameritas Investment Company held 44,232 shares of Galectin Therapeutics worth $172K as of Q3 2021.
  • Ameritas Investment Company bought 5,000 Galectin Therapeutics shares in Q3 2021, an estimated $16.9K.
  • Galectin Therapeutics made up 0.01% of Ameritas Investment Company's portfolio in Q3 2021, its #687 holding.
  • Ameritas Investment Company first reported a position in Galectin Therapeutics in Q4 2019 and has held it in 7 quarters since.
  • 70 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.